Cambridge Interventional

medical devices

About

Cambridge Interventional is a Massachusetts-based medical device company focused on radiofrequency ablation (RFA) technology for treating thyroid nodules. Founded by Eric R Cosman, Jr, PhD from MIT, the company has a rich history of RFA innovation dating back to 1952. It is ISO 13485:2016 certified and offers the CRF Thyroid Radiofrequency Ablation System, which has received FDA marketing approval and the CE mark for the EU. This system is designed for various applications, including percutaneous and laparoscopic procedures, and features real-time audiovisual feedback and automatic safety shutoff. The company serves clinicians such as endocrinologists, otolaryngologists, and interventional radiologists, providing them with educational resources to integrate RFA technology into their practices. Cambridge Interventional emphasizes the benefits of its technology, which include minimally invasive treatment, reduced risks, and faster recovery for patients. Their commitment to advancing thyroid care aligns with the growing demand for effective medical treatments.

Technologies

Outlook Oracle Cloud Sophos

Keywords

b2b medical equipment and supplies manufacturing compact rf generator percutaneous ablation rf generator system automatic heat retention monitoring healthcare equipment & supplies medical devices fda marketing approval regulatory approvals thyroid ablation liver tumor ablation coaxial electrode design internally-cooled rf system ablation system medical device development heat retention monitoring steerable ablation probe minimally invasive therapy large spherical ablation zones cost-effective electrodes touch screen interface real-time feedback electrode options iso 13485:2016 ce mark thermal ablation biopsy before ablation pulsing algorithm ex-vivo bovine liver studies

Location

78 Cambridge St, Burlington, Massachusetts, United States, 01803

Related Companies

Companies in the same industry